TD Cowen analyst Dan Brennan lowered the firm’s price target on Bruker (BRKR) to $55 from $70 and keeps a Hold rating on the shares. The firm ...

Stifel lowered the firm’s price target on Bruker (BRKR) to $57 from $70 and keeps a Hold rating on the shares. Bruker continues to show ...

Bruker Corporation BRKR delivered adjusted earnings per share (EPS) of 76 cents for the fourth quarter of 2024, up 8.6% year over year. The figure surpassed the Zacks Consensus Estimate by 1.3%. The ...

Bruker Corp (BRKR) reports a 14.6% increase in Q4 revenue and sets optimistic guidance for 2025 despite challenges in Asia ...

Discover key takeaways from Bruker Corporation's Q4 2024 earnings call, highlighting strong diagnostics, semiconductor growth, and confident 2025 ...

Corporation reported its fourth-quarter 2024 earnings, surpassing analysts' expectations with an earnings per share (EPS) of $0.76 against the forecast of $0.74. Revenue also exceeded projections, ...

Anti-Microbial/Anti-Fungal Tests MarketThe global anti-microbial/anti-fungal tests market is poised for significant growth, ...

Researchers make use of small-angle X-ray scattering to reveal potential-dependent structural changes in redox enzymes used ...